Medicinal Chemistry Support Program for Therapeutic Development (MCSP)

Description: The National Institute on Drug Abuse is seeking capability information for the Medicinal Chemistry Support Program for Therapeutic Development, which would provide comprehensive medicinal chemistry services supporting preclinical drug discovery and therapeutic development. Respondents should demonstrate full-service capabilities, qualified personnel, capacity for multiple concurrent projects, and the ability to perform activities such as exploratory chemistry, hit-to-lead, lead optimization, synthesis, computational chemistry, and in vitro ADMET studies. This active notice is a Sources Sought request for market research and explicitly states that it is not a solicitation for competitive proposals or quotations; responses are due September 14, 2026.